Position in CRSP
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$54,540
+$6,970 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#356
of 519 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $984,033 across 14 Biotechnology names. CRSP ranks #2 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,739 | $863,813 | |
| 2 | CRSP |
CRISPR Therapeutics AG
This page
|
1,000 | $54,540 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20 | $12,470 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
48 | $11,566 | |
| 5 | EXEL |
Exelixis, Inc.
|
201 | $10,936 | |
| 6 | TECH |
BIO-TECHNE Corp
|
128 | $9,043 | |
| 7 | INCY |
Incyte Corp
|
65 | $7,368 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
18 | $5,418 |
All Filings in CRSP
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,540 | 1,000 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $47,570 | 1,000 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $52,440 | 1,000 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $64,810 | 1,000 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $48,640 | 1,000 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $34,030 | 1,000 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $39,360 | 1,000 | Shares | Sole | 2025-01-10 | |
| No filing history on record for this holder in this stock. | ||||||